Cargando…
Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175859/ https://www.ncbi.nlm.nih.gov/pubmed/32387757 http://dx.doi.org/10.1016/j.mehy.2020.109758 |
_version_ | 1783524912751706112 |
---|---|
author | Cherri, Sara Noventa, Silvia Zaniboni, Alberto |
author_facet | Cherri, Sara Noventa, Silvia Zaniboni, Alberto |
author_sort | Cherri, Sara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7175859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71758592020-04-22 Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? Cherri, Sara Noventa, Silvia Zaniboni, Alberto Med Hypotheses Article Elsevier Ltd. 2020-08 2020-04-22 /pmc/articles/PMC7175859/ /pubmed/32387757 http://dx.doi.org/10.1016/j.mehy.2020.109758 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Cherri, Sara Noventa, Silvia Zaniboni, Alberto Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
title | Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
title_full | Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
title_fullStr | Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
title_full_unstemmed | Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
title_short | Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
title_sort | is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175859/ https://www.ncbi.nlm.nih.gov/pubmed/32387757 http://dx.doi.org/10.1016/j.mehy.2020.109758 |
work_keys_str_mv | AT cherrisara istheoncologicpatientmoresusceptibletocovid19butperhapslesslikelytoundergosevereinfectionrelatedcomplicationsduetofewercytokinesstormasaconsequentoftheassociatedimmunodeficiency AT noventasilvia istheoncologicpatientmoresusceptibletocovid19butperhapslesslikelytoundergosevereinfectionrelatedcomplicationsduetofewercytokinesstormasaconsequentoftheassociatedimmunodeficiency AT zanibonialberto istheoncologicpatientmoresusceptibletocovid19butperhapslesslikelytoundergosevereinfectionrelatedcomplicationsduetofewercytokinesstormasaconsequentoftheassociatedimmunodeficiency |